Status:
TERMINATED
Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
Lead Sponsor:
Oregon Health and Science University
Conditions:
Mevalonic Aciduria
Mevalonate Kinase Deficiency
Eligibility:
All Genders
Brief Summary
Participants wanted for study of mevalonate kinase deficiency (MKD), mevalonic aciduria, or hyperimmunoglobulinemia with periodic fever syndrome (HIDS). Patients with MKD (mevalonic aciduria or hyper...
Detailed Description
Participants are admitted to the clinical research center for up to a week per visit. Additional visits at least yearly encouraged. During the week we measure such things as cholesterol absorption, st...
Eligibility Criteria
Inclusion
- Must have documented mevalonate kinase deficiency, mevalonic aciduria, or HIDS
- Must be willing to participate in most research procedures
Exclusion
- Unable or unwilling to participate in most research procedures
Key Trial Info
Start Date :
February 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2016
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00260299
Start Date
February 1 2005
End Date
January 31 2016
Last Update
May 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239